Gamma Investing LLC Neurocrine Biosciences Inc Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Gamma Investing LLC holds 2,355 shares of NBIX stock, worth $303,535. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,355
Previous 1,981
18.88%
Holding current value
$303,535
Previous $219 Million
35.1%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
650Shares Held
97.3MCall Options Held
743KPut Options Held
464K-
Black Rock Inc. New York, NY14.2MShares$1.83 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.26 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$718 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$576 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$344 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...